Phase Ib/II trial of quizartinib, decitabine and venetoclax in FLT3-ITD-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 4:15 3 years ago 190 Далее Скачать
A Phase I/II study evaluating quizartinib plus decitabine and venetoclax in FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 4:03 2 years ago 122 Далее Скачать
Quizartinib, venetoclax, and decitabine in patients with FLT3-ITD AML: a Phase I/II trial VJHemOnc – Video Journal of Hematology & HemOnc 1:27 9 months ago 129 Далее Скачать
Update on Phase I/II study of azacitidine, venetoclax and gilteritinib in patients with FLT3+ AML VJHemOnc – Video Journal of Hematology & HemOnc 2:11 2 years ago 83 Далее Скачать
Dr. Levis on a Phase II Trial Examining Quizartinib in AML Targeted Oncology 3:00 12 years ago 228 Далее Скачать
Highlights in AML: quizartinib in elderly patients & in frontline FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 0:51 2 years ago 57 Далее Скачать
Quizartinib for frontline FLT3-ITD+ AML: updated results from the QuANTUM-First trial VJHemOnc – Video Journal of Hematology & HemOnc 2:35 1 year ago 536 Далее Скачать
Decitabine and venetoclax for AML VJHemOnc – Video Journal of Hematology & HemOnc 6:21 4 years ago 1 748 Далее Скачать
Gilteritinib plus venetoclax for R/R FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 6:38 4 years ago 503 Далее Скачать
VEN-A-QUI: low-dose cytarabine or azacitidine+venetoclax and quizartinib in older patients with AML VJHemOnc – Video Journal of Hematology & HemOnc 4:13 2 years ago 393 Далее Скачать
Dr. Levis Discusses the Ideal Use of Quizartinib in FLT3-ITD AML OncLive 1:18 10 years ago 451 Далее Скачать
QuANTUM-R: quizartinib looks promising for FLT3-ITD mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 4:09 5 years ago 141 Далее Скачать
TP53-mutant AML linked to poorer outcomes with decitabine plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:48 3 years ago 314 Далее Скачать
Triplet combination of azacitidine, venetoclax & gilteritinib for patients with FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 2:42 2 years ago 273 Далее Скачать
Update on QuANTUM-First: quizartinib + SOC chemotherapy & as continuation therapy in FLT3-ITD+ AML VJHemOnc – Video Journal of Hematology & HemOnc 3:31 2 years ago 299 Далее Скачать
Azacitidine, venetoclax and gilteritinib for patients with FLT3-mutated acute myeloid leukaemia ecancer 7:01 2 years ago 129 Далее Скачать
Developments in targeted AML therapies: venetoclax, quizartinib & gilteritinib VJHemOnc – Video Journal of Hematology & HemOnc 3:15 6 years ago 252 Далее Скачать
Comparing outcomes of 10-day decitabine with venetoclax vs. chemotherapy in AML based on fitness VJHemOnc – Video Journal of Hematology & HemOnc 9:17 4 years ago 211 Далее Скачать
Tangible benefit for FLT3-ITD R/R AML on quizartinib VJHemOnc – Video Journal of Hematology & HemOnc 1:59 5 years ago 193 Далее Скачать
